Shengtan Wang

ORCID: 0000-0003-4649-714X · 2 papers in corpus
other 2022
Medicine ·doi:10.1097/md.0000000000031146

To apply a network pharmacological approach to explore the targets and possible mechanisms of Kai Yu Zhong Yu Tang (KYZYT) in the treatment of tubal fimbria obstruction. The target information of KYZYT was extracted from TCMSP and HERB data…

nonrandomized-trial 2021
Journal of Obstetrics and Gynaecology Research ·doi:10.1111/jog.15031

AIM: The levonorgestrel-releasing intrauterine (LNG-IUS) system is an effective primary treatment for adenomyosis; however, it has high expulsion rates. We aimed to modify the system-allowing affixion to the myometrium-and evaluate the expu…